Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Operating Leases (2019 - 2025)

Harvard Bioscience (HBIO) has disclosed Operating Leases for 7 consecutive years, with $6.9 million as the latest value for Q4 2025.

  • Quarterly Operating Leases fell 8.71% to $6.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.9 million through Dec 2025, down 8.71% year-over-year, with the annual reading at $6.9 million for FY2025, 8.71% down from the prior year.
  • Operating Leases for Q4 2025 was $6.9 million at Harvard Bioscience, down from $8.8 million in the prior quarter.
  • The five-year high for Operating Leases was $8.8 million in Q2 2025, with the low at $4.4 million in Q3 2023.
  • Average Operating Leases over 5 years is $6.7 million, with a median of $6.9 million recorded in 2021.
  • The sharpest move saw Operating Leases plummeted 41.21% in 2023, then surged 58.66% in 2025.
  • Over 5 years, Operating Leases stood at $8.6 million in 2021, then fell by 14.06% to $7.4 million in 2022, then fell by 16.27% to $6.2 million in 2023, then rose by 21.4% to $7.5 million in 2024, then decreased by 8.71% to $6.9 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $6.9 million, $8.8 million, and $8.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.